NYSE: HLFHerbalife Ltd Stock
$6.99+0.20 (+2.95%)
Updated May 8, 2025
HLF Price
$6.99
Fair Value Price
N/A
Market Cap
$711.91M
52 Week Low
$5.04
52 Week High
$12.79
P/E
2.51x
P/B
-0.97x
P/S
0.18x
PEG
N/A
Dividend Yield
N/A
Revenue
$4.95B
Earnings
$280.40M
Gross Margin
78.1%
Operating Margin
8.86%
Profit Margin
5.7%
Debt to Equity
-4.65
Operating Cash Flow
$272M
Beta
0.87
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HLF Overview
Herbalife Nutrition Ltd. sells dietary supplements. Herbalife Nutrition's products include weight-loss and protein shakes, as well as protein bars, teas, aloes, vitamins, and sports hydration, energy, and personal care products. The company was best known for its original product, the Formula 1 protein shake, a soy-based meal-replacement shake. The company was founded in 1980 and is headquartered in the Cayman Islands.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HLF's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Food
Industry Rating
B
HLF
Ranked#11 of 49
Ranked#11 of 49
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $11.88 | A | |
| $14.32 | A | |
| $47.30 | A |
Be the first to know about important HLF news, forecast changes, insider trades & much more!
HLF News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HLF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HLF is forecast by analysts to be unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
HLF is good value based on its earnings relative to its share price (2.51x), compared to the US market average (24.22x)
P/E vs Market Valuation
HLF is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more HLF due diligence checks available for Premium users.
Valuation
HLF price to earnings (PE)
For valuing profitable companies with steady earnings
Company
2.51x
Industry
19.25x
Market
24.22x
HLF is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HLF is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HLF price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-0.97x
Industry
1.89x
HLF's financial health
Profit margin
Revenue
$1.2B
Net Income
$50.4M
Profit Margin
4.1%
HLF's Earnings (EBIT) of $438.60M... subscribe to Premium to read more.
Interest Coverage Financials
HLF's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.7B
Liabilities
$3.4B
Debt to equity
-4.65
HLF's short-term liabilities ($1.13B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HLF's long-term liabilities ($2.29B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HLF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HLF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$200.0k
Investing
-$18.8M
Financing
-$72.2M
HLF's operating cash flow ($271.80M)... subscribe to Premium to read more.
Debt Coverage Financials
HLF vs Food Stocks
Herbalife Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.